Found: 14
Select item for more details and to access through your institution.
A phase II study of vorinostat ( MK-0683) in patients with polycythaemia vera and essential thrombocythaemia.
- Published in:
- British Journal of Haematology, 2013, v. 162, n. 4, p. 498, doi. 10.1111/bjh.12416
- By:
- Publication type:
- Article
Outcome and characteristics of non‐measurable myeloma: A cohort study with population‐based data from the Swedish Myeloma Registry.
- Published in:
- European Journal of Haematology, 2020, v. 104, n. 5, p. 376, doi. 10.1111/ejh.13351
- By:
- Publication type:
- Article
Cytokine Measurements for Diagnosing and Characterizing Leukemoid Reactions and Immunohistochemical Validation of a Granulocyte Colony-Stimulating Factor and CXCL8-Producing Renal Cell Carcinoma.
- Published in:
- Biomarker Insights, 2018, n. 13, p. 1, doi. 10.1177/1177271918792246
- By:
- Publication type:
- Article
Incidence, characteristics, and outcome of solitary plasmacytoma and plasma cell leukemia. Population-based data from the Swedish Myeloma Register.
- Published in:
- European Journal of Haematology, 2017, v. 99, n. 3, p. 216, doi. 10.1111/ejh.12907
- By:
- Publication type:
- Article
Thalidomide and dexamethasone vs. bortezomib and dexamethasone for melphalan refractory myeloma: a randomized study.
- Published in:
- European Journal of Haematology, 2012, v. 88, n. 6, p. 485, doi. 10.1111/j.1600-0609.2012.01775.x
- By:
- Publication type:
- Article
A phase II trial of pegylated interferon α‐2b therapy for polycythemia vera and essential thrombocythemiaData management and statistical analyses were performed by Hans Garmo and Gunilla Juhlin at the regional Oncologic Center in Uppsala, Sweden.: Feasibility, clinical and biologic effects, and impact on quality of life
- Published in:
- Cancer (0008543X), 2006, v. 106, n. 11, p. 2397
- By:
- Publication type:
- Article
A phase II trial of pegylated interferon alpha-2b therapy for polycythemia vera and essential thrombocythemia: feasibility, clinical and biologic effects, and impact on quality of life.
- Published in:
- 2006
- By:
- Publication type:
- journal article
Over 10 years relative median survival in MM patients ≤ 65 years with VGPR or better on 1st line treatment. Population-based data on patients diagnosed 2008-2018 from the Swedish Myeloma Registry.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e209, doi. 10.1016/j.clml.2019.09.347
- By:
- Publication type:
- Article
Maintenance treatment with azacytidine for patients with high-risk myelodysplastic syndromes (MDS) or acute myeloid leukaemia following MDS in complete remission after induction chemotherapy.
- Published in:
- British Journal of Haematology, 2010, v. 150, n. 3, p. 293, doi. 10.1111/j.1365-2141.2010.08235.x
- By:
- Publication type:
- Article
Impact of age on survival after intensive therapy for multiple myeloma: a population-based study by the Nordic Myeloma Study Group.
- Published in:
- British Journal of Haematology, 2006, v. 133, n. 4, p. 389, doi. 10.1111/j.1365-2141.2006.06042.x
- By:
- Publication type:
- Article
A validated decision model for treating the anaemia of myelodysplastic syndromes with erythropoietin + granulocyte colony-stimulating factor: significant effects on quality of life.
- Published in:
- British Journal of Haematology, 2003, v. 120, n. 6, p. 1037, doi. 10.1046/j.1365-2141.2003.04153.x
- By:
- Publication type:
- Article
Intensive chemotherapy in patients with chronic myelogenous leukaemia (CML) in accelerated or blastic phase – a report from the Swedish CML Group.
- Published in:
- British Journal of Haematology, 2002, v. 118, n. 4, p. 1048, doi. 10.1046/j.1365-2141.2002.03765.x
- By:
- Publication type:
- Article
High-dose cytarabine in upfront therapy for adult patients with acute lymphoblastic leukaemia.
- Published in:
- British Journal of Haematology, 2002, v. 118, n. 3, p. 748, doi. 10.1046/j.1365-2141.2002.03685.x
- By:
- Publication type:
- Article
Intensive Treatment and Stem Cell Transplantation in Chronic Myelogenous Leukemia: Long-Term Follow-Up.
- Published in:
- Acta Haematologica, 2005, v. 113, n. 3, p. 155, doi. 10.1159/000084445
- By:
- Publication type:
- Article